

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.40962589 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89772281 |
| 3 | respiratory burst (GO:0045730) | 3.84073050 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 3.63216479 |
| 5 | central nervous system myelination (GO:0022010) | 3.63216479 |
| 6 | signal peptide processing (GO:0006465) | 3.59360364 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53986150 |
| 8 | protein neddylation (GO:0045116) | 3.53679207 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.51667682 |
| 10 | fatty acid elongation (GO:0030497) | 3.48076972 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32925768 |
| 12 | mast cell activation (GO:0045576) | 3.32673318 |
| 13 | positive regulation of macrophage differentiation (GO:0045651) | 3.29167206 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.21623392 |
| 15 | actin nucleation (GO:0045010) | 3.17555259 |
| 16 | phagosome maturation (GO:0090382) | 3.15444759 |
| 17 | B cell mediated immunity (GO:0019724) | 3.13441791 |
| 18 | amyloid precursor protein catabolic process (GO:0042987) | 3.12135505 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.11114473 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.05999446 |
| 21 | cytidine metabolic process (GO:0046087) | 3.04091022 |
| 22 | cytidine catabolic process (GO:0006216) | 3.04091022 |
| 23 | cytidine deamination (GO:0009972) | 3.04091022 |
| 24 | thrombin receptor signaling pathway (GO:0070493) | 3.03461318 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.01782536 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01782536 |
| 27 | leukocyte aggregation (GO:0070486) | 3.01713733 |
| 28 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.00806283 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 2.95651797 |
| 30 | sequestering of actin monomers (GO:0042989) | 2.95561642 |
| 31 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.95380563 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90429967 |
| 33 | amyloid precursor protein metabolic process (GO:0042982) | 2.90118005 |
| 34 | regulation of regulatory T cell differentiation (GO:0045589) | 2.87701285 |
| 35 | T cell migration (GO:0072678) | 2.87228233 |
| 36 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87116505 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87116505 |
| 38 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.85266284 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83512880 |
| 40 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79791694 |
| 41 | regulation of chronic inflammatory response (GO:0002676) | 2.79406716 |
| 42 | lymphocyte chemotaxis (GO:0048247) | 2.78659995 |
| 43 | regulation of platelet aggregation (GO:0090330) | 2.77617274 |
| 44 | DNA deamination (GO:0045006) | 2.76422668 |
| 45 | dendritic cell chemotaxis (GO:0002407) | 2.76392838 |
| 46 | lipoxygenase pathway (GO:0019372) | 2.75613516 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.75542982 |
| 48 | proteasome assembly (GO:0043248) | 2.75344852 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75186351 |
| 50 | cellular response to interferon-beta (GO:0035458) | 2.74989605 |
| 51 | neutrophil activation (GO:0042119) | 2.74964298 |
| 52 | eosinophil chemotaxis (GO:0048245) | 2.74791209 |
| 53 | regulation of tolerance induction (GO:0002643) | 2.72861795 |
| 54 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.69938491 |
| 55 | positive regulation of tolerance induction (GO:0002645) | 2.69716298 |
| 56 | regulation of platelet activation (GO:0010543) | 2.69699011 |
| 57 | negative regulation of T cell apoptotic process (GO:0070233) | 2.66956091 |
| 58 | phagocytosis, engulfment (GO:0006911) | 2.66529077 |
| 59 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.66388095 |
| 60 | leukocyte degranulation (GO:0043299) | 2.66162745 |
| 61 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.64612681 |
| 62 | regulation of T cell migration (GO:2000404) | 2.63791695 |
| 63 | respiratory electron transport chain (GO:0022904) | 2.61528297 |
| 64 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.59770520 |
| 65 | ATP synthesis coupled proton transport (GO:0015986) | 2.59770520 |
| 66 | mannosylation (GO:0097502) | 2.58494624 |
| 67 | electron transport chain (GO:0022900) | 2.57521183 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57408393 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.57241230 |
| 70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.56902510 |
| 71 | regulation of type 2 immune response (GO:0002828) | 2.56440330 |
| 72 | granulocyte activation (GO:0036230) | 2.56375618 |
| 73 | response to interferon-beta (GO:0035456) | 2.56193707 |
| 74 | dendritic cell migration (GO:0036336) | 2.55912391 |
| 75 | negative regulation of interleukin-17 production (GO:0032700) | 2.55673523 |
| 76 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.55125290 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 2.54789951 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54778727 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 2.52348941 |
| 80 | aldehyde catabolic process (GO:0046185) | 2.52310328 |
| 81 | regulation of metalloenzyme activity (GO:0048552) | 2.52185757 |
| 82 | regulation of lymphocyte migration (GO:2000401) | 2.51615960 |
| 83 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.51249109 |
| 84 | mitochondrial calcium ion transport (GO:0006851) | 2.51245415 |
| 85 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.51103935 |
| 86 | positive regulation of type 2 immune response (GO:0002830) | 2.49866584 |
| 87 | fibril organization (GO:0097435) | 2.49597390 |
| 88 | response to peptidoglycan (GO:0032494) | 2.49041804 |
| 89 | GPI anchor biosynthetic process (GO:0006506) | 2.48890584 |
| 90 | eosinophil migration (GO:0072677) | 2.48151375 |
| 91 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.47935634 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47633629 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.47253432 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 2.47253432 |
| 95 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.47210932 |
| 96 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.47210932 |
| 97 | regulation of monocyte chemotaxis (GO:0090025) | 2.46671440 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45596369 |
| 99 | superoxide anion generation (GO:0042554) | 2.44902825 |
| 100 | microglial cell activation (GO:0001774) | 2.44275385 |
| 101 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.44084710 |
| 102 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.44070583 |
| 103 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.43872505 |
| 104 | regulation of interleukin-8 secretion (GO:2000482) | 2.43443565 |
| 105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.43006172 |
| 106 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42796526 |
| 107 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.42430057 |
| 108 | positive regulation of T cell migration (GO:2000406) | 2.40984398 |
| 109 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.40696309 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.40296514 |
| 111 | mast cell activation involved in immune response (GO:0002279) | 2.39515030 |
| 112 | mast cell degranulation (GO:0043303) | 2.39515030 |
| 113 | protein complex biogenesis (GO:0070271) | 2.39295971 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.37648785 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.37523966 |
| 116 | activated T cell proliferation (GO:0050798) | 2.37495210 |
| 117 | membrane raft organization (GO:0031579) | 2.37150716 |
| 118 | regulation of interleukin-17 production (GO:0032660) | 2.36357384 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.35652674 |
| 120 | positive regulation of lymphocyte migration (GO:2000403) | 2.35362587 |
| 121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35120130 |
| 122 | cyclooxygenase pathway (GO:0019371) | 2.34565273 |
| 123 | negative regulation of lipid storage (GO:0010888) | 2.34253997 |
| 124 | platelet aggregation (GO:0070527) | 2.33550724 |
| 125 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.32446508 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.32446508 |
| 127 | negative regulation of viral genome replication (GO:0045071) | 2.32092574 |
| 128 | intracellular pH reduction (GO:0051452) | 2.31352220 |
| 129 | negative regulation of neurotransmitter transport (GO:0051589) | 2.29881927 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.29845390 |
| 131 | cellular response to type I interferon (GO:0071357) | 2.29845390 |
| 132 | nucleotide transmembrane transport (GO:1901679) | 2.28232833 |
| 133 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.27788202 |
| 134 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.26954847 |
| 135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.24553847 |
| 136 | cytochrome complex assembly (GO:0017004) | 2.23934166 |
| 137 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.23397900 |
| 138 | regulation of antigen processing and presentation (GO:0002577) | 2.23207500 |
| 139 | response to type I interferon (GO:0034340) | 2.23184276 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.22627226 |
| 141 | regulation of activation of Janus kinase activity (GO:0010533) | 2.21804249 |
| 142 | platelet dense granule organization (GO:0060155) | 2.21734685 |
| 143 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.19553105 |
| 144 | NADH dehydrogenase complex assembly (GO:0010257) | 2.19553105 |
| 145 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.19553105 |
| 146 | regulation of mast cell activation (GO:0033003) | 2.19537556 |
| 147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.19456685 |
| 148 | pH reduction (GO:0045851) | 2.19178444 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.17617959 |
| 150 | GPI anchor metabolic process (GO:0006505) | 2.17422347 |
| 151 | glycosphingolipid catabolic process (GO:0046479) | 2.17072552 |
| 152 | positive regulation of interleukin-17 production (GO:0032740) | 2.16755197 |
| 153 | cellular defense response (GO:0006968) | 2.15671005 |
| 154 | respiratory chain complex IV assembly (GO:0008535) | 2.14632077 |
| 155 | defense response to protozoan (GO:0042832) | 2.14293507 |
| 156 | transferrin transport (GO:0033572) | 2.13960338 |
| 157 | regulated secretory pathway (GO:0045055) | 2.13885065 |
| 158 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.12897932 |
| 159 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.10601456 |
| 160 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.10601456 |
| 161 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.10561719 |
| 162 | modulation by symbiont of host immune response (GO:0052553) | 2.10561719 |
| 163 | positive regulation by symbiont of host defense response (GO:0052509) | 2.10561719 |
| 164 | modulation by symbiont of host defense response (GO:0052031) | 2.10561719 |
| 165 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.10561719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.37407694 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.28902156 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.01525231 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.85034721 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76149242 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11185984 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.82254206 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.63277232 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35097102 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22855131 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14448365 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12497506 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10638059 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03717428 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00037973 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97545125 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96891861 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93788338 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87630618 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67588012 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.65733102 |
| 22 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63730394 |
| 23 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62504852 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62500342 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62223937 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62142363 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61312972 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59142600 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56091195 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54017989 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.53916118 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49505663 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48845058 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46246441 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45351192 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43029447 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41196192 |
| 38 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.39758568 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38670387 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38197782 |
| 41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37940424 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37868739 |
| 43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.37500367 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36832204 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35058730 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35040446 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31759319 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30856545 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30844955 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29331878 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29181642 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29112025 |
| 53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28539712 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27769586 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27749930 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26936417 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26291571 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25473759 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23170196 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21760130 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20147543 |
| 62 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.20103042 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19976704 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19636765 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19430479 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19260033 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19260033 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18269212 |
| 69 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18059258 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17391037 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16233840 |
| 72 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16176814 |
| 73 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15801915 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14909236 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14631801 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.14324330 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13584281 |
| 78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13425256 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13002389 |
| 80 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12948495 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12885340 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12575849 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11905609 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11801322 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11791289 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11070376 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10790117 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08509927 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07835131 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06446540 |
| 91 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06200853 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05806196 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05436613 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03286569 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02998022 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02775140 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01733175 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01432538 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00710186 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00406140 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00388012 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00012794 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99573539 |
| 104 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99325336 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98057099 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96861965 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96440083 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96317644 |
| 109 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96230388 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95921412 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95851811 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95792235 |
| 113 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94952448 |
| 114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94231765 |
| 115 | * MYB_26560356_Chip-Seq_TH2_Human | 0.94039731 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93803410 |
| 117 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.92799890 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91686458 |
| 119 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91516003 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91388493 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91073993 |
| 122 | * MAF_26560356_Chip-Seq_TH1_Human | 0.91005398 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90986358 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90555086 |
| 125 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90481226 |
| 126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90192198 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.90126280 |
| 128 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90103230 |
| 129 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89743302 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89531317 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89291327 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89176777 |
| 133 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88968853 |
| 134 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88641065 |
| 135 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88641065 |
| 136 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88564005 |
| 137 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.88548613 |
| 138 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87802263 |
| 139 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86695979 |
| 140 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.86675199 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84706111 |
| 142 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84619540 |
| 143 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84059358 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83826407 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83800164 |
| 146 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83360524 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81146336 |
| 148 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80959146 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79340592 |
| 150 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79152168 |
| 151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78147147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.39770187 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.38889860 |
| 3 | MP0009785_altered_susceptibility_to | 3.12185736 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.09843559 |
| 5 | MP0005671_abnormal_response_to | 2.98172841 |
| 6 | MP0006082_CNS_inflammation | 2.83382676 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.62012635 |
| 8 | MP0000920_abnormal_myelination | 2.45394911 |
| 9 | MP0002419_abnormal_innate_immunity | 2.43828726 |
| 10 | MP0005025_abnormal_response_to | 2.37006031 |
| 11 | MP0008004_abnormal_stomach_pH | 2.33982949 |
| 12 | MP0006054_spinal_hemorrhage | 2.26821240 |
| 13 | MP0003880_abnormal_central_pattern | 2.26433789 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.22843069 |
| 15 | MP0005387_immune_system_phenotype | 2.21051392 |
| 16 | MP0001790_abnormal_immune_system | 2.21051392 |
| 17 | MP0003436_decreased_susceptibility_to | 2.18706572 |
| 18 | MP0001905_abnormal_dopamine_level | 2.10555092 |
| 19 | MP0002723_abnormal_immune_serum | 2.02407349 |
| 20 | MP0000685_abnormal_immune_system | 2.02058335 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.94436872 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 1.91653176 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.91442442 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.91115350 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.86806094 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.85710021 |
| 27 | MP0001819_abnormal_immune_cell | 1.84756027 |
| 28 | MP0001800_abnormal_humoral_immune | 1.83949846 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.80959507 |
| 30 | MP0002736_abnormal_nociception_after | 1.77720134 |
| 31 | MP0001529_abnormal_vocalization | 1.76138179 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.63819110 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.62200966 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.61576633 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.57519342 |
| 36 | MP0008260_abnormal_autophagy | 1.54627180 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.54270721 |
| 38 | MP0003690_abnormal_glial_cell | 1.50265582 |
| 39 | MP0005171_absent_coat_pigmentation | 1.49868057 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.48120387 |
| 41 | MP0003136_yellow_coat_color | 1.47468987 |
| 42 | MP0005310_abnormal_salivary_gland | 1.47089407 |
| 43 | MP0002405_respiratory_system_inflammati | 1.46784283 |
| 44 | MP0009763_increased_sensitivity_to | 1.46007307 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.45069457 |
| 46 | MP0005409_darkened_coat_color | 1.41031181 |
| 47 | MP0003279_aneurysm | 1.40580111 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.39865483 |
| 49 | MP0004381_abnormal_hair_follicle | 1.37161274 |
| 50 | MP0002933_joint_inflammation | 1.37011629 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.35259578 |
| 52 | MP0001970_abnormal_pain_threshold | 1.35065424 |
| 53 | MP0001542_abnormal_bone_strength | 1.31902035 |
| 54 | MP0000604_amyloidosis | 1.31545036 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.29310767 |
| 56 | MP0005165_increased_susceptibility_to | 1.27949198 |
| 57 | MP0002722_abnormal_immune_system | 1.26081403 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.25656346 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.24934566 |
| 60 | MP0003186_abnormal_redox_activity | 1.23022076 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.22257814 |
| 62 | MP0000343_altered_response_to | 1.21999141 |
| 63 | MP0008469_abnormal_protein_level | 1.21596446 |
| 64 | MP0000716_abnormal_immune_system | 1.21442024 |
| 65 | MP0001851_eye_inflammation | 1.21046714 |
| 66 | MP0003828_pulmonary_edema | 1.20854455 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.20095442 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.19193774 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.18640619 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.18640619 |
| 71 | MP0009764_decreased_sensitivity_to | 1.16684725 |
| 72 | MP0004142_abnormal_muscle_tone | 1.14642569 |
| 73 | MP0003329_amyloid_beta_deposits | 1.14190257 |
| 74 | MP0005390_skeleton_phenotype | 1.14153647 |
| 75 | MP0004510_myositis | 1.13939425 |
| 76 | MP0001853_heart_inflammation | 1.10088484 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.08836016 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 1.06901170 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.06234566 |
| 80 | MP0005164_abnormal_response_to | 1.06139405 |
| 81 | MP0004742_abnormal_vestibular_system | 1.04856903 |
| 82 | MP0002272_abnormal_nervous_system | 1.04644068 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.04592878 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.03435102 |
| 85 | MP0002064_seizures | 1.02982010 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.02148891 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.01219799 |
| 88 | MP0002398_abnormal_bone_marrow | 1.00302157 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.98626848 |
| 90 | MP0003075_altered_response_to | 0.96689391 |
| 91 | MP0002006_tumorigenesis | 0.96256755 |
| 92 | MP0001188_hyperpigmentation | 0.96147734 |
| 93 | MP0003795_abnormal_bone_structure | 0.90872179 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.90711459 |
| 95 | MP0002132_abnormal_respiratory_system | 0.90508725 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.89735374 |
| 97 | MP0003303_peritoneal_inflammation | 0.88715736 |
| 98 | MP0002429_abnormal_blood_cell | 0.87918598 |
| 99 | MP0003634_abnormal_glial_cell | 0.87631912 |
| 100 | MP0004947_skin_inflammation | 0.87196661 |
| 101 | MP0004270_analgesia | 0.86872115 |
| 102 | MP0009745_abnormal_behavioral_response | 0.85769130 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.85179716 |
| 104 | MP0000490_abnormal_crypts_of | 0.84657445 |
| 105 | MP0000249_abnormal_blood_vessel | 0.84276405 |
| 106 | MP0005023_abnormal_wound_healing | 0.83556749 |
| 107 | MP0002163_abnormal_gland_morphology | 0.82712567 |
| 108 | MP0001663_abnormal_digestive_system | 0.82621256 |
| 109 | MP0001958_emphysema | 0.82385801 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.81039485 |
| 111 | MP0003633_abnormal_nervous_system | 0.80972347 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.80246973 |
| 113 | MP0000858_altered_metastatic_potential | 0.80241922 |
| 114 | MP0003011_delayed_dark_adaptation | 0.79796914 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.79382119 |
| 116 | MP0004883_abnormal_blood_vessel | 0.79334546 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.79167134 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.79116979 |
| 119 | MP0005645_abnormal_hypothalamus_physiol | 0.78902649 |
| 120 | MP0005166_decreased_susceptibility_to | 0.78777237 |
| 121 | MP0004782_abnormal_surfactant_physiolog | 0.78196574 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.77511484 |
| 123 | MP0003448_altered_tumor_morphology | 0.76782686 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.76049097 |
| 125 | MP0003866_abnormal_defecation | 0.75891672 |
| 126 | MP0005275_abnormal_skin_tensile | 0.74251939 |
| 127 | MP0009840_abnormal_foam_cell | 0.74225221 |
| 128 | MP0005410_abnormal_fertilization | 0.74003754 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.72923825 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.70293710 |
| 131 | MP0009278_abnormal_bone_marrow | 0.67212720 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.67053037 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.63951216 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.63789430 |
| 135 | MP0008873_increased_physiological_sensi | 0.63356704 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.62131265 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.59875633 |
| 138 | MP0008874_decreased_physiological_sensi | 0.59211279 |
| 139 | MP0004272_abnormal_basement_membrane | 0.58385805 |
| 140 | MP0004147_increased_porphyrin_level | 0.57599560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 5.16021155 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.63052964 |
| 3 | Increased mean platelet volume (HP:0011877) | 4.19732153 |
| 4 | Abnormal platelet volume (HP:0011876) | 4.19350711 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.10984115 |
| 6 | Epistaxis (HP:0000421) | 4.05720985 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.99719857 |
| 8 | Menorrhagia (HP:0000132) | 3.92993941 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.82251701 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80601626 |
| 11 | Parakeratosis (HP:0001036) | 3.73849739 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.70181052 |
| 13 | Hypothermia (HP:0002045) | 3.64524539 |
| 14 | Gingival bleeding (HP:0000225) | 3.54227666 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.52262670 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.46538879 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.40296823 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.28009632 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.26579816 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.21632979 |
| 21 | Myositis (HP:0100614) | 3.13415501 |
| 22 | Stomatitis (HP:0010280) | 3.11082163 |
| 23 | Progressive macrocephaly (HP:0004481) | 3.03822935 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.00215589 |
| 25 | Obstructive lung disease (HP:0006536) | 2.99816932 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99816932 |
| 27 | Recurrent skin infections (HP:0001581) | 2.99214349 |
| 28 | Hepatocellular necrosis (HP:0001404) | 2.88334541 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88249730 |
| 30 | Abnormal platelet function (HP:0011869) | 2.86079047 |
| 31 | Impaired platelet aggregation (HP:0003540) | 2.86079047 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.83842931 |
| 33 | Increased IgM level (HP:0003496) | 2.82643196 |
| 34 | Acute encephalopathy (HP:0006846) | 2.81192607 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.79275876 |
| 36 | Optic neuritis (HP:0100653) | 2.79275876 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71517208 |
| 38 | Hepatosplenomegaly (HP:0001433) | 2.70861905 |
| 39 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68802046 |
| 40 | Purpura (HP:0000979) | 2.68344070 |
| 41 | Joint swelling (HP:0001386) | 2.67972593 |
| 42 | Encephalitis (HP:0002383) | 2.67013354 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.63522145 |
| 44 | Increased CSF lactate (HP:0002490) | 2.59211312 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.49200247 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.49200247 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.49083843 |
| 48 | Orchitis (HP:0100796) | 2.48110670 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47575071 |
| 50 | Nausea (HP:0002018) | 2.47414505 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.45399370 |
| 52 | Conjunctival telangiectasia (HP:0000524) | 2.45085560 |
| 53 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.42511880 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.41266264 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.40984969 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.40534968 |
| 57 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36691146 |
| 58 | Abnormal hair whorl (HP:0010721) | 2.35991741 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35312036 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.32438688 |
| 61 | Hepatic necrosis (HP:0002605) | 2.30151868 |
| 62 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.29979375 |
| 63 | Exertional dyspnea (HP:0002875) | 2.27869131 |
| 64 | Axonal loss (HP:0003447) | 2.27714374 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.27311875 |
| 66 | Abnormality of T cells (HP:0002843) | 2.26967108 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.26954307 |
| 68 | Eosinophilia (HP:0001880) | 2.26206140 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25056640 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25056640 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25056640 |
| 72 | Optic disc pallor (HP:0000543) | 2.24309905 |
| 73 | Patchy hypopigmentation of hair (HP:0011365) | 2.22568002 |
| 74 | Meningitis (HP:0001287) | 2.22314021 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.22271490 |
| 76 | Vasculitis (HP:0002633) | 2.19640375 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18916473 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18916473 |
| 79 | Gangrene (HP:0100758) | 2.18604124 |
| 80 | Increased serum ferritin (HP:0003281) | 2.17010061 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.16548192 |
| 82 | Peripheral hypomyelination (HP:0007182) | 2.15833507 |
| 83 | Neuroendocrine neoplasm (HP:0100634) | 2.15321255 |
| 84 | Leukodystrophy (HP:0002415) | 2.15184931 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.14127616 |
| 86 | Abnormality of the prostate (HP:0008775) | 2.13508081 |
| 87 | Petechiae (HP:0000967) | 2.11286686 |
| 88 | Chronic otitis media (HP:0000389) | 2.11021725 |
| 89 | Abnormality of renal resorption (HP:0011038) | 2.10854393 |
| 90 | Granulocytopenia (HP:0001913) | 2.10006692 |
| 91 | Anorexia (HP:0002039) | 2.08192010 |
| 92 | Glomerulopathy (HP:0100820) | 2.08072764 |
| 93 | Pulmonary fibrosis (HP:0002206) | 2.07086265 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.07001793 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.04576398 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 2.04552845 |
| 97 | Recurrent pneumonia (HP:0006532) | 2.04447115 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.01984927 |
| 99 | Polyneuropathy (HP:0001271) | 2.00143004 |
| 100 | Generalized aminoaciduria (HP:0002909) | 1.99865447 |
| 101 | Urticaria (HP:0001025) | 1.99612582 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.99504110 |
| 103 | Loss of speech (HP:0002371) | 1.95929859 |
| 104 | Type I transferrin isoform profile (HP:0003642) | 1.95595239 |
| 105 | Arterial thrombosis (HP:0004420) | 1.95100148 |
| 106 | White forelock (HP:0002211) | 1.94840021 |
| 107 | Respiratory failure (HP:0002878) | 1.94535786 |
| 108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94479841 |
| 109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94479841 |
| 110 | Autoamputation (HP:0001218) | 1.93488228 |
| 111 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93355475 |
| 112 | Abnormality of T cell number (HP:0011839) | 1.93271942 |
| 113 | Abnormal pupillary function (HP:0007686) | 1.91552803 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90811348 |
| 115 | Pheochromocytoma (HP:0002666) | 1.88212481 |
| 116 | Gingivitis (HP:0000230) | 1.87930303 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.85004387 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.83789023 |
| 119 | T lymphocytopenia (HP:0005403) | 1.83173058 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 1.82885605 |
| 121 | Abnormality of secondary sexual hair (HP:0009888) | 1.81768713 |
| 122 | Abnormality of the axillary hair (HP:0100134) | 1.81768713 |
| 123 | Bruising susceptibility (HP:0000978) | 1.81680064 |
| 124 | Dyschromatopsia (HP:0007641) | 1.80051673 |
| 125 | Erythema (HP:0010783) | 1.79789194 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.79439580 |
| 127 | Myocardial infarction (HP:0001658) | 1.78551704 |
| 128 | Mutism (HP:0002300) | 1.77980392 |
| 129 | Basal ganglia calcification (HP:0002135) | 1.77545298 |
| 130 | Chest pain (HP:0100749) | 1.76692370 |
| 131 | Disinhibition (HP:0000734) | 1.76545979 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76194470 |
| 133 | Medial flaring of the eyebrow (HP:0010747) | 1.76151784 |
| 134 | IgG deficiency (HP:0004315) | 1.75971244 |
| 135 | Exercise intolerance (HP:0003546) | 1.75432307 |
| 136 | Amaurosis fugax (HP:0100576) | 1.74882410 |
| 137 | Recurrent viral infections (HP:0004429) | 1.74798978 |
| 138 | Leukocytosis (HP:0001974) | 1.74738820 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 1.74613091 |
| 140 | Abnormality of eosinophils (HP:0001879) | 1.73521519 |
| 141 | Sensory axonal neuropathy (HP:0003390) | 1.72907842 |
| 142 | Amyloidosis (HP:0011034) | 1.72491287 |
| 143 | Hemoptysis (HP:0002105) | 1.71850782 |
| 144 | IgM deficiency (HP:0002850) | 1.71652283 |
| 145 | Panhypogammaglobulinemia (HP:0003139) | 1.71260590 |
| 146 | Cerebral inclusion bodies (HP:0100314) | 1.70242934 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.69678431 |
| 148 | Episodic fever (HP:0001954) | 1.69270668 |
| 149 | Xerostomia (HP:0000217) | 1.68585008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.06950004 |
| 2 | MAP3K12 | 2.92282393 |
| 3 | TXK | 2.79123287 |
| 4 | CASK | 2.49193540 |
| 5 | MST4 | 2.43783722 |
| 6 | PBK | 2.42654573 |
| 7 | IRAK4 | 2.39359836 |
| 8 | TESK1 | 2.32822603 |
| 9 | RIPK4 | 2.32335956 |
| 10 | STK16 | 2.05540320 |
| 11 | NME2 | 2.05311341 |
| 12 | MAP3K14 | 2.03091626 |
| 13 | ARAF | 2.00898509 |
| 14 | PIM2 | 2.00214840 |
| 15 | STK39 | 1.96059238 |
| 16 | GRK7 | 1.91468000 |
| 17 | ADRBK2 | 1.86959164 |
| 18 | IKBKE | 1.84086895 |
| 19 | BMPR1B | 1.82797233 |
| 20 | MAP4K1 | 1.82459812 |
| 21 | MAPKAPK5 | 1.82197190 |
| 22 | TBK1 | 1.79197262 |
| 23 | KIT | 1.69194456 |
| 24 | EIF2AK1 | 1.64170668 |
| 25 | TNIK | 1.57522062 |
| 26 | OXSR1 | 1.57189283 |
| 27 | TEC | 1.53132435 |
| 28 | MYLK | 1.41362625 |
| 29 | TRIM28 | 1.39206103 |
| 30 | EPHB1 | 1.37928752 |
| 31 | CDK19 | 1.37137029 |
| 32 | BMPR2 | 1.36677591 |
| 33 | IRAK3 | 1.35358510 |
| 34 | BMX | 1.26612134 |
| 35 | BCR | 1.23962680 |
| 36 | MAP4K2 | 1.23378886 |
| 37 | CLK1 | 1.22606745 |
| 38 | FES | 1.19219206 |
| 39 | LIMK1 | 1.19128530 |
| 40 | SYK | 1.19082141 |
| 41 | GRK5 | 1.18672682 |
| 42 | IRAK1 | 1.17975581 |
| 43 | ZAP70 | 1.15944404 |
| 44 | TYK2 | 1.14844443 |
| 45 | ITK | 1.14590815 |
| 46 | LCK | 1.13966733 |
| 47 | MUSK | 1.13711679 |
| 48 | MAP3K3 | 1.11082662 |
| 49 | IRAK2 | 1.06851434 |
| 50 | TESK2 | 1.06582546 |
| 51 | TAOK2 | 1.05379097 |
| 52 | SIK3 | 1.01706183 |
| 53 | IKBKB | 1.00670774 |
| 54 | LYN | 0.99142698 |
| 55 | FGR | 0.98210421 |
| 56 | BCKDK | 0.96588461 |
| 57 | JAK3 | 0.96498805 |
| 58 | KDR | 0.94368108 |
| 59 | MAPKAPK3 | 0.93993669 |
| 60 | PAK4 | 0.90170440 |
| 61 | DAPK1 | 0.89632943 |
| 62 | BTK | 0.89142580 |
| 63 | CSNK1G2 | 0.88377553 |
| 64 | MAP2K7 | 0.87527526 |
| 65 | PRKCQ | 0.86334643 |
| 66 | NLK | 0.85273218 |
| 67 | MAP3K11 | 0.85075281 |
| 68 | NTRK1 | 0.84550911 |
| 69 | PRPF4B | 0.83723525 |
| 70 | SCYL2 | 0.83313793 |
| 71 | NEK6 | 0.80868116 |
| 72 | TLK1 | 0.80622606 |
| 73 | DDR2 | 0.78563616 |
| 74 | MAP3K5 | 0.76881149 |
| 75 | CSNK1G3 | 0.75272112 |
| 76 | VRK1 | 0.73985882 |
| 77 | STK24 | 0.73817194 |
| 78 | PKN1 | 0.72115569 |
| 79 | CSK | 0.70940213 |
| 80 | PAK1 | 0.70166077 |
| 81 | NUAK1 | 0.68658986 |
| 82 | PLK2 | 0.68468151 |
| 83 | DAPK3 | 0.68373389 |
| 84 | TRPM7 | 0.67692232 |
| 85 | TIE1 | 0.67339037 |
| 86 | PDK2 | 0.65648316 |
| 87 | TNK2 | 0.65573915 |
| 88 | EPHA3 | 0.65100069 |
| 89 | CSF1R | 0.64212465 |
| 90 | ACVR1B | 0.63393444 |
| 91 | JAK2 | 0.62967386 |
| 92 | CAMK2B | 0.62513268 |
| 93 | MATK | 0.62297544 |
| 94 | ERN1 | 0.61388724 |
| 95 | ABL2 | 0.61200673 |
| 96 | PRKCE | 0.60903170 |
| 97 | MAP3K13 | 0.59070203 |
| 98 | ADRBK1 | 0.58594703 |
| 99 | JAK1 | 0.57677394 |
| 100 | MAPK15 | 0.57459471 |
| 101 | HCK | 0.57349521 |
| 102 | ROCK2 | 0.56738574 |
| 103 | PRKCD | 0.56348928 |
| 104 | YES1 | 0.55826481 |
| 105 | MAPK13 | 0.54898713 |
| 106 | CDK8 | 0.54860152 |
| 107 | EIF2AK3 | 0.54251542 |
| 108 | STK10 | 0.51999252 |
| 109 | ABL1 | 0.51974466 |
| 110 | ERBB3 | 0.51241448 |
| 111 | RPS6KA5 | 0.49782851 |
| 112 | TAOK3 | 0.49609740 |
| 113 | CSNK1A1L | 0.47623918 |
| 114 | CAMK2A | 0.47378998 |
| 115 | NME1 | 0.46865114 |
| 116 | CAMKK2 | 0.46698803 |
| 117 | PTK2B | 0.46356177 |
| 118 | BUB1 | 0.43910550 |
| 119 | FYN | 0.43634443 |
| 120 | MARK3 | 0.43152155 |
| 121 | CAMK2D | 0.42941645 |
| 122 | CSNK1G1 | 0.42732622 |
| 123 | PIK3CG | 0.42369386 |
| 124 | MAPK4 | 0.42189246 |
| 125 | ILK | 0.41662811 |
| 126 | CAMK2G | 0.41132732 |
| 127 | DYRK2 | 0.40588381 |
| 128 | GRK1 | 0.39932509 |
| 129 | STK3 | 0.39370439 |
| 130 | MOS | 0.38784982 |
| 131 | DYRK3 | 0.38679295 |
| 132 | FGFR4 | 0.38478660 |
| 133 | EGFR | 0.37929675 |
| 134 | GRK6 | 0.37812892 |
| 135 | TGFBR2 | 0.37532461 |
| 136 | LMTK2 | 0.37166335 |
| 137 | MAPKAPK2 | 0.36826642 |
| 138 | CDK14 | 0.36299588 |
| 139 | PIM1 | 0.36014249 |
| 140 | IGF1R | 0.35542019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.56714714 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.07899652 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.66934527 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56115775 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.47963306 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.34472996 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.24395448 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.23886506 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.14550451 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.11723584 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.08240119 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.96864353 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95283027 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.94291953 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87186798 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.84831518 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83813444 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78953772 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.72873666 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.66308088 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62239633 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60229187 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59819712 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57813519 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.57535136 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55057040 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52944643 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52884917 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.50648179 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.49009608 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.48324201 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46973616 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46169482 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41914328 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38498452 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34381562 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27437923 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13646282 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.10086806 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.06722535 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.04734264 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04638975 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02986248 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01550886 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00628677 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99809494 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99773352 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97913108 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97369942 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95005764 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92631240 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91887187 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91399922 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90170236 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89457499 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88835013 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87145626 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86699616 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84513296 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.82925086 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82857091 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82407968 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81880419 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81044098 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.80204917 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78268972 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.77281108 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75504760 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75259322 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73778944 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.71603723 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66791242 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.64191549 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60057095 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58948452 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58029610 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58004569 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56815964 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56471110 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56205371 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56148606 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54577816 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52536927 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50812895 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.48767374 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47612918 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.47505288 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.45050009 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42994280 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42826723 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42767815 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42751330 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42213979 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40248643 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39247839 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38800480 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37385115 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.36159779 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.36084958 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35654073 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33727185 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33628809 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33404152 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32905301 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31620821 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.31579537 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31105534 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.30835035 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30135367 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.28860377 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28388450 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27809540 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27784402 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.26386095 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.26289902 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.25907071 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.25777571 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.24786730 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.24742684 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24559860 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16724819 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14688424 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13268838 |

